"The Wellcome HRB CRF (CRF) is fully embedded in St James’s Hospital and is central to the clinical research activity taking place on campus. Located at the heart of St James’s Hospital it supports and conducts a wide range of studies from observational studies to complex clinical trials."

During the past decade, Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital" #1 sponsor was "St. James's Hospital, Ireland" with 6 trials, followed by "Galapagos NV" with 2 trials sponsored, "Neuromod Devices Ltd." with 2 trials sponsored, "Caitríona Quinn" with 1 trials sponsored and "University of Dublin, Trinity College" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital" #1 collaborator was "University College Dublin" with 3 trials as a collaborator, "University of Dublin, Trinity College" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Göteborg University" with 2 trials as a collaborator and "Liverpool John Moores University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital" are "Esophageal Cancer" (3 trials), "Esophageal Neoplasms" (3 trials), "Malnutrition" (3 trials), "Stomach Neoplasms" (3 trials) and "Surgery" (3 trials). Many other conditions were trialed in "Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital" in a lesser frequency.

Most popular intervention types in "Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital" are "Drug" (5 trials), "Device" (2 trials), "Diagnostic Test" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Filgotinib" (2 trials), "Octreotide" (2 trials), "Active Stand" (1 trials) and "Coenzyme Q10" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".